| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2019: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2018: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2016: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2015: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
|
|---|
| Outline of Final Research Achievements |
We conducted a multicenter prospective observational study of active cancer and ischemic stroke at nine stroke centers in Japan. Eligible patients were followed up to 1 year after ischemic stroke. During the study periods, 135 patients who had active cancer and ischemic stroke were enrolled (median age, 75 years; 52 [38.5%] were female). The most common type of cancer was lung cancer, and 77 (57.0%) patients had and advanced cancer. Analyses showed that the survival probability after ischemic stroke was 54.1% at 1 year. The cumulative incidence of recurrent stroke and major bleeding were 10.3% and 9.0%, respectively.
|
